Wordt geladen...

Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma

Cancers of the stomach and gastro-esophageal junction represent a significant challenge in oncology. Despite some recent advances in genetic categorization and the development of novel agents, outcomes remain poor. The vascular endothelial growth factor receptor 2 monoclonal antibody ramucirumab is...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Onco Targets Ther
Hoofdauteurs: Davidson, Michael, Smyth, Elizabeth C, Cunningham, David
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966750/
https://ncbi.nlm.nih.gov/pubmed/27524910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S84153
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!